Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies. Postel-Vinay, S.; Aspeslagh, S.; Lanoy, E.; Robert, C.; Soria, J. C.; Marabelle, A.. Ann Oncol. 2016; 214-24: p.214-24. doi:10.1093/annonc/mdv550 10.1093/annonc/mdv550. Epub 2015 Nov 16.Article
Oncostat